We collected information about Geron Corp Hours for you. Follow the liks to find out everything about Geron Corp Hours.
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Imetelstat: a first-in-class telomerase inhibitor. A unique molecule targeting a hallmark of cancer. 2021 Virtual Annual Meeting of Stockholders.
https://www.nasdaq.com/market-activity/stocks/gern/after-hours
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET).
https://catchingnews.com/2021/11/02/on-what-basis-did-geron-corp-gern-stock-rise-5-after-hours/
The shares of Geron Corporation (GERN) traded at $1.65 in after-hours trading at last check, with a gain of 5.09%. In Monday’s session, GERN closed at $1.57 with a gain of 1.95%. Stock volume stayed at 2.86 million shares, a higher volume than the average daily volume of 1.72 million shares ov
https://www.barrons.com/market-data/stocks/gern?mod=DNH_S
Complete Geron Corp. stock information by Barron's. View real-time GERN stock price and news, along with industry-best analysis.
https://finance.yahoo.com/quote/GERN
Find the latest Geron Corporation (GERN) stock quote, history, news and other vital information to help you with your stock trading and investing.
https://www.marketwatch.com/investing/Stock/GERN
GERN | Complete Geron Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166313884
After hours up .18, so far. *GERON ANNOUNCES PUBLICATION OF ANALYSES COMPARING REAL WORLD DATA TO IMBARK PHASE 2 IN ANNALS OF HEMATOLOGY. *GERON CORP- ANALYSES SUGGEST SURVIVAL BENEFIT ASSOCIATED WITH IMETELSTAT TREATMENT IN COMPARISON TO BEST AVAILABLE THERAPY. *GERON CORP- OVERALL SURVIVAL IS …
https://ir.geron.com/home/default.aspx
Geron is committed to improving and extending the lives of patients by changing the course of these diseases by targeting telomerase. We are currently focused on the development and potential commercialization of imetelstat, a first in class telomerase inhibitor, and are conducting two ongoing Phase 3 clinical trials that are intended to enable ...
https://www.barrons.com/market-data/stocks/gern
Complete Geron Corp. stock information by Barron's. View real-time GERN stock price and news, along with industry-best analysis.
https://www.cnbc.com/quotes/GERN
Get Geron Corp (GERN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Searching for Geron Corp Hours?
You can just click the links above. The info is collected for you.
